ArticleNeuropsychopharmacology reports2026
Changes in White Blood Cell and Neutrophil Counts in Patients With Schizophrenia Treated With Lithium Carbonate, Adenine, and Ninjin-Yoei-To: A Preliminary Study.
Article in Neuropsychopharmacology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimClozapine is often unavailable to patients with treatment-resistant schizophrenia when white blood cell (WBC) and neutrophil counts do not meet the required thresholds. This study aimed to examine changes in WBC and neutrophil counts and the factors associated with these changes.
methodsThirty-five patients with schizophrenia who received adenine, Ninjin-yoei-to, or lithium carbonate were included in the treatment group. Eighty-one patients with schizophrenia comprised the control group. A two-way mixed analysis of variance (ANOVA) was used to compare changes in WBC and neutrophil counts before and after treatment. Stepwise multiple regression analyses were conducted to identify factors associated with changes in WBC and neutrophil counts.
resultsIn the two-way mixed ANOVA, WBC and neutrophil counts in the treatment group were significantly lower than those in the control group at baseline (p < 0.001), and the counts at the final examination were significantly higher than the baseline values in the treatment group (p < 0.001). Stepwise multiple regression analyses revealed that adenine and lithium carbonate were significant predictors of changes in WBC (adjusted R
conclusionLithium carbonate and adenine may help increase the WBC and neutrophil counts in patients with schizophrenia. These agents may be useful for patients with low WBC and neutrophil counts prior to initiating clozapine treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.